The applications of pharmacogenomics to neurological disorders

Curr Mol Med. 2014;14(7):880-90. Gilman C, McSweeney C, Mao Y1 Abstract The most common neurological disorders, including neurodegenerative diseases and psychiatric disorders, have received recent attention with regards to pharmacogenomics and personalized medicine. Here, we will focus on a neglected neurodegenerative disorder, cerebral ischemic stroke (CIS), and highlight recent advances in two disorders, Parkinson’s disease(…)